GLP-1 RAs showed trends toward improvements in endocrine and metabolic, cardiovascular, renal, and respiratory outcomes, cognitive function, with a potential reduction in fracture risk and all-cause mortality in certain populations
Counterintuitive but consistent: clients who train regularly on GLP-1 medications report higher sustained energy than those who remain sedentary, despite the caloric deficit
The molecular stability of semaglutide depends on maintaining its specific peptide conformation
Stool Softener: Miralax vs
1500 mg of L-Citrulline per Capsule - 90 Capsules per Bottle., 1000 mg of L-Carnitine per Tablet - 60 Tablets per Bottle
Document PBS criteria : inadequate control on metformin SU/insulin, plus any SGLT2-i contraindication or prior failure if combining